• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, November 20, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Network Analysis Identifies Four Key Target Genes for Herbal Decoction in Heart Failure

by
November 16, 2026
in Health
Reading Time: 7 mins read
0
Network Analysis Identifies Four Key Target Genes for Herbal Decoction in Heart Failure

Network Analysis Identifies Four Key Target Genes for Herbal Decoction in Heart Failure

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A computational investigation combining network pharmacology, bioinformatics, and ensemble machine learning has identified four core target genes through which the traditional herbal formulation modified Lai-Fu decoction may intervene in chronic heart failure by modulating myocardial lipid metabolism reprogramming. Chronic heart failure represents a multifaceted clinical syndrome driven by coronary artery disease, hypertension, obesity, and type 2 diabetes mellitus, affecting an estimated population exceeding 56 million individuals across the globe. Within the healthy myocardium, an immense metabolic expenditure requires approximately 30 kilograms of adenosine triphosphate each day to sustain continuous contractile function, relying primarily on fatty acid oxidation for cellular energy generation. However, pathological progression in heart failure is characterized by severe disruptions in energy regulation, neural activation, chronic inflammation, and metabolic aging, which jointly trigger cellular insulin resistance and toxic intracellular lipid accumulation. While established guidelines from the European Society of Cardiology recommend pharmacotherapies including angiotensin receptor-neprilysin inhibitors, beta-blockers, mineralocorticoid receptor antagonists, and sodium-glucose cotransporter 2 inhibitors, disease incidence and mortality continue an upward trajectory. Seeking to clarify the mechanistic foundations of modified Lai-Fu decoction, an herbal formula historically documented in The Records of Traditional Chinese and Western Medicine in Combination, investigators analyzed its active constituent compounds against public transcriptomic profiles of failing human hearts.

The traditional decoction under evaluation incorporates seven distinct medicinal components: Cornus officinalis, also known as Shanzhuyu; ginseng, designated Renshen; Aconitum carmichaelii, termed Fuzi; Zingiber officinale, or Ganjiang; Ossa draconis, known as Longgu; Crassostrea gigas, or Muli; and Glycyrrhiza uralensis, known as Gancao. In clinical applications, the mixture has demonstrated capacity to ameliorate patient symptoms and improve overall quality of life, yet the precise molecular mechanisms governing its bioactivity have remained uncharacterized. To systematically identify the active botanical ingredients and their corresponding biological targets, researchers screened the Traditional Chinese Medicine Systems Pharmacology database and the HERB database, implementing threshold criteria requiring oral bioavailability of at least 30 percent and drug likeness scores of at least 0.18. Redundant entries, compounds sharing identical chemical formulas, and duplicate botanical designations were systematically purged, while remaining chemical components were standardized against the UniProt knowledgebase. For compounds lacking direct target documentation, canonical SMILES strings were extracted from PubChem and processed through the SwissTargetPrediction platform to forecast human protein binding targets. Through this multi-step filtration procedure, the research team isolated 46 verified bioactive ingredients across the seven constituent herbs, which corresponded to a total of 289 non-redundant human target genes.

To establish a rigorous disease gene framework, the investigators acquired gene expression profiles from the Gene Expression Omnibus repository under accessions GSE57345 and GSE116250. The primary discovery cohort, GSE57345, comprised 136 healthy control tissue samples and 177 chronic heart failure samples, while the GSE116250 series encompassed 14 control samples and 50 disease samples, with neither dataset featuring stratification by patient sex or gender. Differential expression profiling of the primary discovery matrix using the limma package in R identified 445 differentially expressed genes meeting statistical cutoffs of absolute log2 fold change greater than 0.5 and P less than 0.05, consisting of 238 significantly upregulated genes and 207 significantly downregulated genes. Concurrently, data mining within the GeneCards platform using a relevance score threshold exceeding 10 retrieved 2,645 genes associated with heart failure and 1,278 genes linked to lipid metabolism reprogramming. Merging the differentially expressed transcripts with the GeneCards disease targets yielded a consolidated collection of 2,989 heart failure-related genes. An intersection analysis between this expanded disease gene set and the 289 herbal targets revealed 144 overlapping candidate genes, representing prospective molecular touchpoints through which active chemical constituents in modified Lai-Fu decoction could exert therapeutic influence over cardiac tissue.

Functional enrichment interrogations conducted on these 144 intersecting target genes via the ClusterProfiler package in R elucidated the biological pathways potentially responsive to herbal intervention. Kyoto Encyclopedia of Genes and Genomes pathway enrichment demonstrated statistically significant overrepresentation in the phosphoinositide 3-kinase and protein kinase B signaling axis, the mitogen-activated protein kinase cascade, hypoxia-inducible factor 1 signaling, and insulin signaling pathways. In addition, the target genes displayed strong involvement in metabolic disease pathways, notably non-alcoholic fatty liver disease and insulin resistance. Complementary Gene Ontology enrichment analyses validated that the candidate drug targets were predominantly concentrated within biological processes governing responses to nutrient levels, physiological responses to insulin stimulation, cellular fatty acid metabolic processes, regulation of overall lipid metabolism, and adipocyte differentiation. In the clinical course of heart failure, energy production undergoes pathological remodeling wherein early disease stages feature heightened fatty acid uptake that exceeds oxidative capacity, diverting unoxidized lipids into triacylglycerol and provoking lipotoxic myocardial damage. As cardiac failure deteriorates further, impaired mitochondrial structural integrity and reduced enzymatic expression diminish oxidation efficiency, forcing an adverse shift toward glucose dependence and worsening myocardial contractile failure.

To delineate coherent transcriptional architectures within the clinical samples, the investigators performed weighted gene coexpression network analysis across the normalized expression data using the WGCNA package in R. After excluding genes within the lowest 50 percent of median absolute deviation values to eliminate uninformative background variance and applying hierarchical clustering to purge sample outliers, researchers determined a soft-thresholding power of beta equals 4, which yielded a scale-free topology fit index R-squared exceeding 0.8. The resulting topological overlap matrix clustered coexpressed transcripts into 20 distinct modules following a module merging similarity cutoff of 0.75. Subsequent correlation assessments linking module eigengenes to clinical phenotypes identified two modules exhibiting exceptionally robust positive associations with heart failure: the darkgreen module, exhibiting a correlation coefficient of 0.64 with P less than 0.0001, and the lightcyan module, showing a correlation coefficient of 0.68 with P less than 0.0001. Scatterplot evaluations demonstrated strong positive linear correlations between gene significance for heart failure and intramodular connectivity, demonstrating that the structural hubs within these two modules constitute critical biological drivers in the progressive pathogenesis of myocardial failure.

To pinpoint target genes simultaneously implicated in herbal pharmacology, heart failure progression, and metabolic reprogramming, the investigators crossed four datasets: the 144 overlapping drug-disease genes, the module genes from the darkgreen and lightcyan coexpression modules, the complete heart failure-related gene library, and the GeneCards lipid metabolism reprogramming genes. This four-way intersection converged upon 15 pivotal candidate genes. When these candidates were mapped into a protein-protein interaction network using the STRING database with an interaction confidence score threshold above 0.4 and visualized in Cytoscape, all proteins demonstrated extensive mutual interrelationships with the solitary exception of dipeptidyl peptidase-4. A compound-target interaction network constructed for the remaining 14 interconnected candidates indicated that these shared targets serve as foundational nodes regulating myocardial metabolic reprogramming. To reduce dimensionality and extract the most predictive disease features from this network, the researchers deployed two machine learning algorithms: the Least Absolute Shrinkage and Selection Operator regression with ten-fold cross-validation at one standard error of minimum mean squared error, alongside the Boruta random forest feature selection algorithm comparing original features against permuted shadow variables. This feature selection pipeline distilled the candidates down to nine core genes: ADRB2, CCND1, ESR1, JAK2, MAPK8, PIK3CA, PIK3CB, SLC2A1, and STAT1.

The diagnostic and prognostic robustness of these selected target molecules was subsequently assessed by constructing machine learning predictive architectures within the caret modeling framework. The researchers trained seven distinct algorithms across a 7:3 random split of the GSE57345 dataset: Logistic Regression, Random Forest, eXtreme Gradient Boosting, Support Vector Machine, Naive Bayes, Gradient Boosting Machine, and LASSO regression, with five-fold cross-validation applied to safeguard generalization performance. When individual performance curves were generated using the pROC package, Random Forest, eXtreme Gradient Boosting, and Gradient Boosting Machine achieved the highest diagnostic accuracy across datasets. Feature attribution via the SHapley Additive exPlanations algorithm, computed across 50 random sampling simulations, ranked the importance of each feature in predicting heart failure status. Four hub genes consistently emerged at the top of feature importance rankings across all three leading algorithmic architectures: MAPK8, CCND1, PIK3CB, and SLC2A1. When an ensemble stacking meta-model combining multiple base learners via a linear model was restricted solely to these four hub biomarkers, it maintained outstanding area under the receiver operating characteristic curve performance in both the training and testing partitions of GSE57345, as well as within the fully independent GSE116250 validation cohort.

Downstream mechanistic evaluations focused specifically on the biological roles assumed by these four validated hub genes during cardiac lipid metabolism reprogramming. By filtering heart failure genes and lipid metabolism reprogramming genes that exhibited strong statistical correlations with the hub targets at criteria of r greater than 0.4 and P less than 0.05, researchers constructed targeted interaction networks and functional enrichment pathways. Protein interaction mapping revealed that MAPK8, CCND1, PIK3CB, and SLC2A1 form dense functional partnerships with structural proteins orchestrating lipid transport, fatty acid degradation, and local inflammatory signaling. Kyoto Encyclopedia of Genes and Genomes enrichment confirmed that their interacting network was significantly enriched in the hypoxia-inducible factor 1 pathway, advanced glycation end products and receptor signaling, fatty acid breakdown cascades, and cellular insulin resistance. Furthermore, Spearman rank correlation analyses established that expression variations in CCND1, PIK3CB, MAPK8, and SLC2A1 correlated significantly with standard biological markers mediating myocardial fatty acid uptake, systemic lipid transport, and de novo lipogenesis, cementing their direct connection to cardiac metabolic status.

To explore the physical binding feasibility between these predicted hub proteins and bioactive small molecules identified within modified Lai-Fu decoction, the researchers conducted computational molecular docking simulations using AutoDock Vina in AutoDockTools. Three-dimensional chemical structures of herbal ligands were retrieved from PubChem, while high-resolution target crystal structures were acquired from the Protein Data Bank. The resulting molecular docking simulations revealed favorable binding energies across multiple core interactions. Cyclin D1, encoded by CCND1, docked stably with the compound 3,6-epoxy-5,3′,4′-trihydroxy-12′,13′,20′-trinor-beta,beta-caroten-19,11-olide with an estimated affinity of -7.4 kilocalories per mole. The PIK3CB catalytic subunit bound to 3,4-dihydroxy-3′,6′-epoxy-1′,2′,5′,6′,7′,8′-hexahydro-6′-methyl-16′-nor-beta,phi-carotene-1′,8′-dione at -7.5 kilocalories per mole. Meanwhile, the MAPK8 kinase domain formed stable complexes with 3,4-dihydroxy-3′,6′-epoxy-1′,2′,5′,6′,7′,8′-hexahydro-6′-methyl-16′-nor-beta,phi-carotene-1′,8′-dione at -7.6 kilocalories per mole, with 3,6-epoxy-5,3′,4′-trihydroxy-12′,13′,20′-trinor-beta,beta-caroten-19,11-olide at -7.7 kilocalories per mole, and with the flavonoid kaempferol at -8.2 kilocalories per mole. Finally, the glucose transporter GLUT1, encoded by SLC2A1, demonstrated strong binding affinity to the flavonoid isoliquiritigenin, producing a docking energy of -8.4 kilocalories per mole.

These computational observations align with established literature describing cardiovascular pharmacology and metabolic regulation, where CCND1 controls the cell cycle transition from G1 to S phase, PIK3CB coordinates cardiomyocyte proliferation and survival through the Hippo-YAP and PI3K-Akt cascades, MAPK8 influences apoptosis and fibrotic remodeling, and SLC2A1 optimizes glucose utilization. Prior studies have similarly established that the botanical monomers kaempferol and isoliquiritigenin can attenuate myocardial injury, with isoliquiritigenin specifically demonstrated to boost cardiac lactate levels and enhance energy availability. Nonetheless, the authors emphasize several notable methodological limitations inherent to their study design. Because the primary findings were derived exclusively from public transcriptomic databases, bioinformatics tools, and machine learning algorithms, they remain vulnerable to database-specific curation biases and cross-study batch effects. Furthermore, the molecular docking calculations provide preliminary structural predictions rather than experimentally verified biochemical binding kinetics. Finally, the study was conducted entirely in silico and lacks wet-laboratory validation in biological systems. The authors conclude that while modified Lai-Fu decoction appears to target CCND1, PIK3CB, MAPK8, and SLC2A1 to modulate lipid metabolism reprogramming, rigorous in vitro cellular assays and in vivo animal experiments are essential to substantiate these predicted therapeutic mechanisms.

Subject of Research: Bioinformatic and network pharmacology identification of modified Lai-Fu decoction targets in chronic heart failure

Article Title: Exploring the Mechanism of Action of Modified Lai-Fu Decoction in Chronic Heart Failure Based on Bioinformatics and Network Pharmacology

Article References: An, J., Niu, H., Xie, H., Lin, Y., Zhang, L., Qin, D., & Zhang, S. (2026). Exploring the Mechanism of Action of Modified Lai-Fu Decoction in Chronic Heart Failure Based on Bioinformatics and Network Pharmacology. Innovations in Acupuncture and Medicine, 19(1), Article 31. https://doi.org/10.1186/s44424-026-00073-z

Image Credits: AI Generated

DOI: 10.1186/s44424-026-00073-z

Keywords: Modified Lai-Fu decoction, Chronic heart failure, Network pharmacology, Bioinformatics, Lipid metabolism reprogramming, CCND1, PIK3CB, MAPK8, SLC2A1, Kaempferol, Isoliquiritigenin, WGCNA, Ensemble machine learning, Molecular docking, Cardiomyocytes, Insulin resistance, Gene Expression Omnibus

News Source: Juliet Wilcox. (November 16, 2026). Network Analysis Identifies Four Key Target Genes for Herbal Decoction in Heart Failure. Scienmag.

Tags: BioinformaticscardiomyocytesCCND1chronic heart failureensemble machine learningGene Expression Omnibusinsulin resistanceIsoliquiritigeninkaempferollipid metabolism reprogrammingMAPK8Modified Lai-Fu decoctionmolecular dockingnetwork pharmacologyPIK3CBSLC2A1WGCNA
Share12Tweet7Share2ShareShareShare1

Related Posts

Only 8.4 Percent of Men Perform Monthly Testicular Self-Examinations

Only 8.4 Percent of Men Perform Monthly Testicular Self-Examinations

November 20, 2026
Sodium Channel Variant Linked to Lower Nerve Burden in Colorectal Cancer

Sodium Channel Variant Linked to Lower Nerve Burden in Colorectal Cancer

November 20, 2026

Knee Replacement Techniques Shift Component Rotation but Share Five-Year Clinical Outcomes

November 20, 2026

Acanthamoeba Keratitis Mimicking Viral Endotheliitis Progresses to Spontaneous Corneal Sloughing

November 20, 2026

POPULAR NEWS

  • Astrocytic GFAP Upregulation Reduces Tau Pathology in Mouse Model of Tauopathy

    Astrocytic GFAP Upregulation Reduces Tau Pathology in Mouse Model of Tauopathy

    29 shares
    Share 12 Tweet 7
  • Acidic Ponds Link to Lower Pathogen Prevalence in Palmate Newts

    29 shares
    Share 12 Tweet 7
  • Early YAP and Beta-Catenin Signaling Links Stomach Infection to Liver Colonization

    29 shares
    Share 12 Tweet 7
  • Cold Storage Preserves Peach Firmness by Triggering RNA Degradation of Expansin Transcripts

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Mammalian Herbivores Exhibit Evolutionary Adaptations Resisting Mammary Cancer Development

Only 8.4 Percent of Men Perform Monthly Testicular Self-Examinations

Biophilic Design Framework Connects Urban Green Spaces to Measurable Mental Well-Being

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.